Daily as of 3 Nov 16:00 ET
- Price
- above both $698.34 vs 50 $657.11 / 200 $552.06
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 18 Aug 2026 · projected 22 bars out
TMO | Thermo Fisher ScientificNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history
$698.34
+$15.69 (+2.30%)
Thermo Fisher Scientific (TMO) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $697.00 vs 50 $556.01 / 200 $536.97
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 17 Aug 2026 · projected 5 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $698.34 vs 50 $678.08 / 200 $600.48
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 7 Jul 2026 · projected 19 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 18 Aug 2026 | 🟨Golden steep | daily | 22 bars out | Not tested |
| week of 17 Aug 2026 | 🟨Golden flat | weekly | 5 bars out | Not tested |
| 7 Jul 2026 | 🟨Golden | 4-hour | 19 bars out | Not tested |
| 6 Apr 2026 | 💀Death steep | daily | 26 bars out | 3 bar cross test |
| 23 Feb 2026 | 💀Death | 4-hour | 29 bars out | Not tested |
About TMO
ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$1.3B
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandmega